While not identified in the primary screen, CD133 has previously been a focus of CD expression research on neural tumours [25, 28, 29, 50] and so its tumour identifying potential on Ptch1lox/lox;GFAPcre medulloblastoma cells was also investigated. Here, PROM1 is linked to neoplasm.